update on phase i/ii study of glofitamab monotherapy in r/r mcl
Published 1 year ago • 58 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:35
update on phase i study of plamotamab in r/r nhl
-
3:58
extended follow-up of glofitamab monotherapy in r/r lbcl: durability of cr and likelihood of crs
-
3:05
updates on the phase i study of ft-4202 for scd
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:03
an update on the phase ii/iii imerge trial of imetelstat in lr-mds
-
1:44
updates from the phase ii animate trial of nivolumab in r/r chl
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
4:54
beakertv | meet brenda montgomery, msl at biomea fusion
-
2:57:35
arc pg update on cornea series
-
2:10
phase ii study of epd maintenance after second autologous transplant for multiple myeloma
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
3:23
final long-term follow-up results of the relaza2 study: mrd-guided treatment with aza in mds and aml
-
3:40
master class in transplantation and hematology: highlights
-
2:56
updates from the eric assembly
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
1:17
phase ii study of tosedostat in mds
-
1:50
novel treatment regimens under investigation for richter's transformation
-
2:38
optimizing outcomes with pre- and post-transplant interventions
-
3:04
applying molecular understanding of dlbcl to management strategies